These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23261601)

  • 21. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity.
    Choi WT; Nedellec R; Coetzer M; Colin P; Lagane B; Offord RE; Hartley O; Mosier DE
    J Virol; 2012 Sep; 86(18):10218-20. PubMed ID: 22787219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.
    Owais M; Arya SK
    J Hum Virol; 1999; 2(5):270-82. PubMed ID: 10551733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES.
    Pastore C; Picchio GR; Galimi F; Fish R; Hartley O; Offord RE; Mosier DE
    Antimicrob Agents Chemother; 2003 Feb; 47(2):509-17. PubMed ID: 12543651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on CCR5 analogs and affinity peptides.
    Wu Y; Deng R; Wu W
    Protein Eng Des Sel; 2012 Mar; 25(3):97-105. PubMed ID: 22238429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-molecular-weight anti-HIV-1 peptides from the amino-terminal sequence of RANTES: possible lead compounds for coreceptor-directed anti-HIV-1 agents.
    Nishiyama Y; Murakami T; Kurita K; Yamamoto N
    Bioorg Med Chem Lett; 1999 May; 9(10):1357-60. PubMed ID: 10360735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivity.
    Ramnarine EJ; Devico AL; Vigil-Cruz SC
    Bioorg Med Chem Lett; 2006 Jan; 16(1):93-5. PubMed ID: 16236501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
    Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
    AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
    J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES.
    Jin H; Kagiampakis I; Li P; Liwang PJ
    Proteins; 2010 Feb; 78(2):295-308. PubMed ID: 19722264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.
    Kish-Catalone TM; Lu W; Gallo RC; DeVico AL
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1497-509. PubMed ID: 16569870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
    Imai M; Baranyi L; Okada N; Okada H
    Biochem Biophys Res Commun; 2007 Feb; 353(4):851-6. PubMed ID: 17210123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infection.
    Shin N; Solomon K; Zhou N; Wang KH; Garlapati V; Thomas B; Li Y; Covington M; Baribaud F; Erickson-Viitanen S; Czerniak P; Contel N; Liu P; Burn T; Hollis G; Yeleswaram S; Vaddi K; Xue CB; Metcalf B; Friedman S; Scherle P; Newton R
    J Pharmacol Exp Ther; 2011 Jul; 338(1):228-39. PubMed ID: 21459966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step.
    Oravecz T; Pall M; Norcross MA
    J Immunol; 1996 Aug; 157(4):1329-32. PubMed ID: 8759710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of novel HIV-1 entry inhibitors by RANTES engineering.
    Vangelista L; Secchi M; Lusso P
    Vaccine; 2008 Jun; 26(24):3008-15. PubMed ID: 18243436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HIV-1 peptides derived from partial amino acid sequences of CC-chemokine RANTES. Regulated upon activation, normal T-cell expressed and secreted.
    Nishiyama Y; Murakami T; Shikama S; Kurita K; Yamamoto N
    Bioorg Med Chem; 2002 Dec; 10(12):4113-7. PubMed ID: 12413865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
    Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
    Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.
    Sabbe R; Picchio GR; Pastore C; Chaloin O; Hartley O; Offord R; Mosier DE
    J Virol; 2001 Jan; 75(2):661-71. PubMed ID: 11134280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.